Production (Stage)
Oragenics, Inc.
OGEN
$4.28
$0.7521.25%
AMEX
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -79.49% | 89.44% | |||
| Gross Profit | 79.49% | -89.44% | |||
| SG&A Expenses | -0.33% | 8.47% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -39.61% | 37.67% | |||
| Operating Income | 39.61% | -37.67% | |||
| Income Before Tax | 33.80% | -35.98% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 33.80% | -35.98% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 33.80% | -35.98% | |||
| EBIT | 39.61% | -37.67% | |||
| EBITDA | -- | -37.78% | |||
| EPS Basic | 56.71% | 25.50% | |||
| Normalized Basic EPS | 56.69% | 25.50% | |||
| EPS Diluted | 56.71% | 25.50% | |||
| Normalized Diluted EPS | 56.69% | 25.50% | |||
| Average Basic Shares Outstanding | 52.87% | 82.54% | |||
| Average Diluted Shares Outstanding | 52.87% | 82.54% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||